NCT00186355已完成不适用
Enrichment and Purging of Stem Cells in the Treatment of Non-Hodgkin's Lymphoma
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 97
- 试验地点
- 2
- 主要终点
- PCR positivity in peripheral blood cell collections after cyclophosphamide
研究概览
简要总结
To evaluate the role of purging the hematopoietic cell graft on outcomes for non-Hodgkin's Lymphoma.
详细描述
To study the use of peripheral blood stem cells which have been treated in an effort to remove tumor cells. The researchers hope to learn whether or not this will be more effective in removing the tumor cells as compared to other methods of purging (the removal of cancer cells).
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 4 Weeks 至 75 Years（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •relapsed NHL
排除标准
- •liver dysfunction
结局指标
主要结局
PCR positivity in peripheral blood cell collections after cyclophosphamide
次要结局
- Enrichment of hematopoietic stem cells
研究者
研究点 (2)
Loading locations...
相似试验
已完成
1 期
Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Pilot Trial of Peripheral Blood Stem Cells (PBSC) as the Donor SourceMDSLymphomaLeukemiaMyelofibrosisNCT02167958Rafic Farah, MD28
已完成
2 期
High Dose Chemotherapy and Allogeneic Hematopoietic Cell Transplant for Non-Hodgkin's LymphomaLymphoma, Non-HodgkinBlood and Marrow Transplant (BMT)Lymphomas: Non-HodgkinNCT00186394Stanford University35
Unknown
2 期
Treatment of Hematologic Malignancies With Single-Unit or Double-Unit Cord Blood TransplantationChronic Myeloid LeukemiaNon-Hodgkin LymphomaMyelodysplastic SyndromesAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaNCT00328237Colorado Blood Cancer Institute20
已完成
不适用
Stem Cell Transplant From Matched Unrelated or Partially Matched Related DonorsBlood CancerBlood and Marrow Transplant (BMT)NCT00186225Stanford University250
终止
不适用
Consolidation PET-based and Donor-based After Salvage Therapy in Patients With HL in Relapse or RefractoryHodgkin's LymphomaNCT00879528Fondazione Italiana Linfomi - ETS264